Grifols SA (GRFS) stock
GRFSNasdaqPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GIKLY
$8.80−0.04 (-0.45%)
Close on Nov 12, 2026Market cap $3.03BP/E 6.7Yield –
Grifols enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Grifols's enterprise value was $7.10B on Nov 11, 2026, against $7.74B a year earlier. Over the last 5 years it ranged from $4.86B to $10.36B, with a median of $8.00B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.10B | -10.9% |
| 2025 | Dec 31, 2025 | $7.97B | -8.1% |
| 2024 | Dec 31, 2024 | $8.67B | -16.4% |
| 2023 | Dec 29, 2023 | $10.36B | +75.1% |
| 2022 | Dec 30, 2022 | $5.92B | -33.8% |
| 2021 | Dec 31, 2021 | $8.94B | -27.9% |
| 2020 | Dec 31, 2020 | $12.39B | -5.7% |
| 2019 | Dec 31, 2019 | $13.14B | +18.8% |
| 2018 | Dec 31, 2018 | $11.06B | +60.3% |
| 2017 | Dec 29, 2017 | $6.90B | +60.8% |
| 2016 | Dec 30, 2016 | $4.29B | – |
See a number that looks wrong?